Median Technologies S.A. is a company focused on providing innovative medical imaging solutions. Specializing in the field of medical imaging and associated technologies, Median Technologies serves as an essential player in the healthcare sector, specifically targeting oncology imaging. The primary function of Median Technologies is to deliver advanced imaging software solutions that enhance and support clinical trials, diagnostics, and treatment monitoring processes for pharmaceutical companies, healthcare institutions, and clinical researchers. A notable feature of the company is its iBiopsy® platform, which is designed to leverage artificial intelligence to improve the accuracy and efficiency of image-based diagnostics. By enabling more precise treatment decisions, Median Technologies plays a crucial role in the development and evaluation of new cancer therapies. Consequently, it is of significant importance in the broader medical technology market, as it directly contributes to advancing precision medicine and improving patient outcomes in oncology care. This positioning highlights its critical role in an industry that demands constant innovation to meet the growing needs of personalized medical treatment.